SE7904276L - RENATED CANCER ASSOCIATED PROTEIN - Google Patents

RENATED CANCER ASSOCIATED PROTEIN

Info

Publication number
SE7904276L
SE7904276L SE7904276A SE7904276A SE7904276L SE 7904276 L SE7904276 L SE 7904276L SE 7904276 A SE7904276 A SE 7904276A SE 7904276 A SE7904276 A SE 7904276A SE 7904276 L SE7904276 L SE 7904276L
Authority
SE
Sweden
Prior art keywords
cadet
iac
renated
associated protein
cancer associated
Prior art date
Application number
SE7904276A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
K B Osther
K F Berg
Original Assignee
Benzon As Alfred
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benzon As Alfred filed Critical Benzon As Alfred
Publication of SE7904276L publication Critical patent/SE7904276L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A purified protein (CaDet) which in SDS Page gradient shows a molecular weight of about 25,000 Daltons has been eluted from antibody affinity columns with immobilized antibodies specifically directed against the protein C1 IAC described in U.S. Patent No. 4,132,769, by elution with a detergent. CaDet reacts with anti C1 IAC in immunoprecipitation tests and, when used for immunization, CaDet gives increased titers of anti C1 IAC.
SE7904276A 1978-05-17 1979-05-15 RENATED CANCER ASSOCIATED PROTEIN SE7904276L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK216378 1978-05-17

Publications (1)

Publication Number Publication Date
SE7904276L true SE7904276L (en) 1979-11-18

Family

ID=8110498

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904276A SE7904276L (en) 1978-05-17 1979-05-15 RENATED CANCER ASSOCIATED PROTEIN

Country Status (15)

Country Link
JP (1) JPS5516291A (en)
AU (1) AU521404B2 (en)
BE (1) BE876301A (en)
DE (1) DE2919833A1 (en)
ES (1) ES480624A1 (en)
FI (1) FI791551A7 (en)
FR (1) FR2426055A1 (en)
GB (1) GB2021593A (en)
IT (1) IT7968046A0 (en)
LU (1) LU81273A1 (en)
NL (1) NL7903854A (en)
NO (1) NO791643L (en)
NZ (1) NZ190470A (en)
PT (1) PT69617A (en)
SE (1) SE7904276L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087898A1 (en) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Antibodies and antigens useful in the diagnosis and treatment of cancer
ZW7583A1 (en) * 1982-04-07 1983-06-29 Baylor College Medicine Products and methods for treatment of cancer

Also Published As

Publication number Publication date
NL7903854A (en) 1979-11-20
DE2919833A1 (en) 1979-11-29
GB2021593A (en) 1979-12-05
LU81273A1 (en) 1979-09-10
NO791643L (en) 1979-11-20
JPS5516291A (en) 1980-02-04
FI791551A7 (en) 1981-01-01
IT7968046A0 (en) 1979-05-17
ES480624A1 (en) 1980-08-16
BE876301A (en) 1979-11-16
FR2426055A1 (en) 1979-12-14
NZ190470A (en) 1982-06-29
AU521404B2 (en) 1982-04-01
PT69617A (en) 1979-06-01
AU4717279A (en) 1979-11-22

Similar Documents

Publication Publication Date Title
ES2106195T3 (en) IGG AGLYCOSILATED ANTIBODY ANTI CD3.
DK0458841T3 (en) Process for use and preparation of peptides
GB2128630A (en) Method of affinity purification employing monoclonal antibodies
DE3854502D1 (en) AGAINST HIV-ANTIGENT SPECIFIC MONOCLONAL ANTIBODIES.
HUT41836A (en) Process for preparing monoclonal antibodies cross-reactive and cross-protecting against p. aeruginosa serotypes
ATE225512T1 (en) SEPARATION PROCESS
East et al. On topographic antigenic determinants in myoglobins
BG40318A3 (en) Method for preparing imunoglobuline derivatives of vindezine
BR9603826A (en) Process to recover immunoglobulin from fractions produced during the fractionation of human blood plasma
YU46858B (en) PROCEDURE FOR OBTAINING IMMUNOGLOBULIN CONJUGATES
SE7904276L (en) RENATED CANCER ASSOCIATED PROTEIN
NO174153C (en) Antigen and monoclonal antibody for use in vitro, as well as immunological reagents containing them
ES8800052A1 (en) A PROCEDURE TO PREPARE AN ANTLENTIC MARGINALE ANTIGENIC SURFACE PROTEIN
Koch et al. Association of surface IgM with two membrane proteins on murine B lymphocytes detected by chemical crosslinking
DK592086A (en) HUMANT CONGLUTININ
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
Hudson et al. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens
NO834535L (en) PROCEDURE FOR AFFINITY CLEANING USING MONOCLONAL ANTIBODIES.
ATE76082T1 (en) PURIFICATION METHOD FOR ANTIBODIES.
Arends [10] Purification of peroxidase-conjugated antibody for enzyme immunoassay by affinity chromatography on concanavalin A
SE8705137D0 (en) DIAGNOSTIC METHOD FOR PRIMARY BILIARY CIRRHOSIS AND ANTIBODIES SUITABLE TO BE USED IN CERTAIN VERSIONS OF THE METHOD
FI925081A7 (en) Method for preparing an antigen-specific, high affinity monoclonal antibody
Worthington et al. Isolation and characterization of antibodies to Clostridium perfringens epsilon toxin from hyperimmune horse serum
Reidl et al. Purification of mouse myelin basic proteins by immunoaffinity chromatography
Sassen et al. Specific precipitation of mouse and rat alpha 2-macroglobulin by immune sera directed against murine leukemia viruses

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7904276-8